The global flow cytometry market is projected to achieve a remarkable compound annual growth rate (CAGR) of 9.2% over the forecast period, driven by technological innovations and increasing adoption rates in clinical diagnostics. Industry leaders such as Becton, Dickinson and Company, Danaher Corporation, and Thermo Fisher Scientific Inc. are at the forefront of this growth. North America currently holds the largest market share, with the Asia Pacific region poised for significant growth.
